Spago Nanomedical AB
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer (NCT06184035) | Spago Nanomedical AB | 2023-12-06 |
| Efficacy of SN132D in Patients With Suspected Endometriosis (NCT05664828) | Spago Nanomedical AB | 2022-11-17 |
| A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (NCT04080024) | Spago Nanomedical AB | 2019-08-23 |
Track Spago Nanomedical AB automatically
Every clearance here is in the API, with alerts when new ones post.